Bharat Biotech founder Dr Krishna Ella bats for incentives, tax breaks for patented products, innovation
Queried about the need for three doses of the COVID-19 vaccine instead of just one, Ella said his company was working on the issue.
Nagpur: Bharat Biotech founder Dr Krishna Ella has batted for "research linked incentives" and tax breaks for new products based on breakthrough and patented innovation done within the country. He was speaking to reporters on the sidelines of the 72nd Indian Pharmaceutical Conference underway here.
Read also: Bharat Biotech partner Ocugen announces positive top-line data for COVID vaccine Covaxin
Bharat Biotech International Limited is an Indian multinational biotechnology company headquartered in Genome Valley, Turakapally, Hyderabad. The company was founded by Krishna Ella in 1996.
It is engaged in the drug discovery, drug development, manufacture of vaccines, bio-therapeutics, pharmaceuticals and health care products.
Read also: Bharat Biotech, Biological E together hold about 250 million COVID vaccine doses
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.